Carcinogenicity of N-Nitrosomethyl(2-oxopropyl)amine in Syrian Hamsters

Parviz Pour, Ralph Gingell, Robert Langenbach, Donald Nagel, Carter Grandjean, Terence Lawson, Shahrokh Salmasi

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

7-Methylguanine was found in hydrolysates of liver and pancreas DNA from Syrian golden hamsters given a single dose of N-[1-14C]nitrosobis(2-oxopropyl)amine (BOP). This led us to examine the carcinogenicity of a potential methylating metabolite of BOP, N-nitrosomethyl(2-oxopropyl)amine (MOP). MOP was found to be a potent pancreatic carcinogen by either single or weekly s.c. injections. A single MOP treatment (25 mg/kg body weight) induced ductular adenomas and/or adenocarcinomas in 80% of the hamsters. A higher incidence of these neoplasms was found in 93% and 87% of animals receiving, respectively, 3.5 and 1.75 mg MOP per kg body weight weekly for life. However, the lower dose (0.87 mg/kg body weight) was less effective, resulting in a 33% tumor incidence. Compared with the known potent pancreatic carcinogen BOP, MOP seemed to have a greater affinity for the pancreas since considerably lower doses were required to induce similar incidences of equivalent pancreatic tumors. Like BOP, MOP caused tumors of the liver (7 to 100% incidence), kidneys (7 to 80% incidence), and vascular system (7 to 27% incidence). However, in contrast to BOP, which was noncarcinogenic to the upper respiratory tract, MOP-treated animals developed a high incidence of nasal cavity tumors (40% after a single treatment and 27 to 100% after weekly injections). The mutagenesis studies using hamster liver cell-mediated V79 cells confirmed the stronger effect of MOP compared to BOP. The assumption that MOP might be a proximate carcinogenic metabolite of BOP could not be substantiated by our methods for determining the in vivo and in vitro metabolites of BOP.

Original languageEnglish (US)
Pages (from-to)3585-3590
Number of pages6
JournalCancer Research
Volume40
Issue number10
StatePublished - Oct 1 1980

Fingerprint

Mesocricetus
Amines
Incidence
Body Weight
nitrosobis(2-oxopropyl)amine
Neoplasms
Cricetinae
Carcinogens
Pancreas
Liver
Injections
Nasal Cavity
Mutagenesis
Respiratory System
Adenoma
Blood Vessels
Adenocarcinoma
Kidney
DNA
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Pour, P., Gingell, R., Langenbach, R., Nagel, D., Grandjean, C., Lawson, T., & Salmasi, S. (1980). Carcinogenicity of N-Nitrosomethyl(2-oxopropyl)amine in Syrian Hamsters. Cancer Research, 40(10), 3585-3590.

Carcinogenicity of N-Nitrosomethyl(2-oxopropyl)amine in Syrian Hamsters. / Pour, Parviz; Gingell, Ralph; Langenbach, Robert; Nagel, Donald; Grandjean, Carter; Lawson, Terence; Salmasi, Shahrokh.

In: Cancer Research, Vol. 40, No. 10, 01.10.1980, p. 3585-3590.

Research output: Contribution to journalArticle

Pour, P, Gingell, R, Langenbach, R, Nagel, D, Grandjean, C, Lawson, T & Salmasi, S 1980, 'Carcinogenicity of N-Nitrosomethyl(2-oxopropyl)amine in Syrian Hamsters', Cancer Research, vol. 40, no. 10, pp. 3585-3590.
Pour P, Gingell R, Langenbach R, Nagel D, Grandjean C, Lawson T et al. Carcinogenicity of N-Nitrosomethyl(2-oxopropyl)amine in Syrian Hamsters. Cancer Research. 1980 Oct 1;40(10):3585-3590.
Pour, Parviz ; Gingell, Ralph ; Langenbach, Robert ; Nagel, Donald ; Grandjean, Carter ; Lawson, Terence ; Salmasi, Shahrokh. / Carcinogenicity of N-Nitrosomethyl(2-oxopropyl)amine in Syrian Hamsters. In: Cancer Research. 1980 ; Vol. 40, No. 10. pp. 3585-3590.
@article{c52f8bb6efb24e1588f1f96bdb0c45a0,
title = "Carcinogenicity of N-Nitrosomethyl(2-oxopropyl)amine in Syrian Hamsters",
abstract = "7-Methylguanine was found in hydrolysates of liver and pancreas DNA from Syrian golden hamsters given a single dose of N-[1-14C]nitrosobis(2-oxopropyl)amine (BOP). This led us to examine the carcinogenicity of a potential methylating metabolite of BOP, N-nitrosomethyl(2-oxopropyl)amine (MOP). MOP was found to be a potent pancreatic carcinogen by either single or weekly s.c. injections. A single MOP treatment (25 mg/kg body weight) induced ductular adenomas and/or adenocarcinomas in 80{\%} of the hamsters. A higher incidence of these neoplasms was found in 93{\%} and 87{\%} of animals receiving, respectively, 3.5 and 1.75 mg MOP per kg body weight weekly for life. However, the lower dose (0.87 mg/kg body weight) was less effective, resulting in a 33{\%} tumor incidence. Compared with the known potent pancreatic carcinogen BOP, MOP seemed to have a greater affinity for the pancreas since considerably lower doses were required to induce similar incidences of equivalent pancreatic tumors. Like BOP, MOP caused tumors of the liver (7 to 100{\%} incidence), kidneys (7 to 80{\%} incidence), and vascular system (7 to 27{\%} incidence). However, in contrast to BOP, which was noncarcinogenic to the upper respiratory tract, MOP-treated animals developed a high incidence of nasal cavity tumors (40{\%} after a single treatment and 27 to 100{\%} after weekly injections). The mutagenesis studies using hamster liver cell-mediated V79 cells confirmed the stronger effect of MOP compared to BOP. The assumption that MOP might be a proximate carcinogenic metabolite of BOP could not be substantiated by our methods for determining the in vivo and in vitro metabolites of BOP.",
author = "Parviz Pour and Ralph Gingell and Robert Langenbach and Donald Nagel and Carter Grandjean and Terence Lawson and Shahrokh Salmasi",
year = "1980",
month = "10",
day = "1",
language = "English (US)",
volume = "40",
pages = "3585--3590",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Carcinogenicity of N-Nitrosomethyl(2-oxopropyl)amine in Syrian Hamsters

AU - Pour, Parviz

AU - Gingell, Ralph

AU - Langenbach, Robert

AU - Nagel, Donald

AU - Grandjean, Carter

AU - Lawson, Terence

AU - Salmasi, Shahrokh

PY - 1980/10/1

Y1 - 1980/10/1

N2 - 7-Methylguanine was found in hydrolysates of liver and pancreas DNA from Syrian golden hamsters given a single dose of N-[1-14C]nitrosobis(2-oxopropyl)amine (BOP). This led us to examine the carcinogenicity of a potential methylating metabolite of BOP, N-nitrosomethyl(2-oxopropyl)amine (MOP). MOP was found to be a potent pancreatic carcinogen by either single or weekly s.c. injections. A single MOP treatment (25 mg/kg body weight) induced ductular adenomas and/or adenocarcinomas in 80% of the hamsters. A higher incidence of these neoplasms was found in 93% and 87% of animals receiving, respectively, 3.5 and 1.75 mg MOP per kg body weight weekly for life. However, the lower dose (0.87 mg/kg body weight) was less effective, resulting in a 33% tumor incidence. Compared with the known potent pancreatic carcinogen BOP, MOP seemed to have a greater affinity for the pancreas since considerably lower doses were required to induce similar incidences of equivalent pancreatic tumors. Like BOP, MOP caused tumors of the liver (7 to 100% incidence), kidneys (7 to 80% incidence), and vascular system (7 to 27% incidence). However, in contrast to BOP, which was noncarcinogenic to the upper respiratory tract, MOP-treated animals developed a high incidence of nasal cavity tumors (40% after a single treatment and 27 to 100% after weekly injections). The mutagenesis studies using hamster liver cell-mediated V79 cells confirmed the stronger effect of MOP compared to BOP. The assumption that MOP might be a proximate carcinogenic metabolite of BOP could not be substantiated by our methods for determining the in vivo and in vitro metabolites of BOP.

AB - 7-Methylguanine was found in hydrolysates of liver and pancreas DNA from Syrian golden hamsters given a single dose of N-[1-14C]nitrosobis(2-oxopropyl)amine (BOP). This led us to examine the carcinogenicity of a potential methylating metabolite of BOP, N-nitrosomethyl(2-oxopropyl)amine (MOP). MOP was found to be a potent pancreatic carcinogen by either single or weekly s.c. injections. A single MOP treatment (25 mg/kg body weight) induced ductular adenomas and/or adenocarcinomas in 80% of the hamsters. A higher incidence of these neoplasms was found in 93% and 87% of animals receiving, respectively, 3.5 and 1.75 mg MOP per kg body weight weekly for life. However, the lower dose (0.87 mg/kg body weight) was less effective, resulting in a 33% tumor incidence. Compared with the known potent pancreatic carcinogen BOP, MOP seemed to have a greater affinity for the pancreas since considerably lower doses were required to induce similar incidences of equivalent pancreatic tumors. Like BOP, MOP caused tumors of the liver (7 to 100% incidence), kidneys (7 to 80% incidence), and vascular system (7 to 27% incidence). However, in contrast to BOP, which was noncarcinogenic to the upper respiratory tract, MOP-treated animals developed a high incidence of nasal cavity tumors (40% after a single treatment and 27 to 100% after weekly injections). The mutagenesis studies using hamster liver cell-mediated V79 cells confirmed the stronger effect of MOP compared to BOP. The assumption that MOP might be a proximate carcinogenic metabolite of BOP could not be substantiated by our methods for determining the in vivo and in vitro metabolites of BOP.

UR - http://www.scopus.com/inward/record.url?scp=0018969439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018969439&partnerID=8YFLogxK

M3 - Article

C2 - 7438045

AN - SCOPUS:0018969439

VL - 40

SP - 3585

EP - 3590

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 10

ER -